Uncategorized
Cenegermin eye drops approved in Europe for neurotrophic keratitis
Cenegermin eye drops received marketing authorization from the European Commission for the treatment of neurotrophic keratitis. This is the first biotechnological treatment available for moderate to severe neurotrophic keratitis, according to a press release from Dompé.